NCT03947489

Bioavailability Study of Two Formulations of Sarpogrelate HCl 300mg Tablets Under Fasting Conditions

A Single-dose, Comparative Bioavailability Study of Two Formulations of Sarpogrelate HCl 300mg Tablets Under Fasting Conditions

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 38 (actual)
• Sponsor: Daewoong Pharmaceutical Co. LTD. · Industry
• Sex: All
• Age: 19 Years
• Healthy volunteers: Accepted

Summary

A Single-dose, Comparative Bioavailability Study of Two Formulations of Sarpogrelate HCl 300mg Tablets Under Fasting Conditions

Detailed description

To evaluate the bioequivalence of two formulations of Sarpogrelate HCl 300mg after a single oral dose administration in healthy volunteers under fasting conditions

Conditions

• Healthy

Interventions

Type	Name	Description
DRUG	Sarpogrelate HCL 300mg	a single oral dose administration in healthy volunteers under fasting condition

Timeline

• Start date: 2019-03-04
• Primary completion: 2019-05-06
• Completion: 2019-05-06
• First posted: 2019-05-13
• Last updated: 2019-05-14

Locations

1 site across 1 country: South Korea